NCC Medical Group is an internationally recognized manufacturer specializing in advanced neurodiagnostic and neuromonitoring technologies. With over two decades of experience in neurophysiology innovation, NCC has become a trusted partner for hospitals, research institutes, and medical distributors worldwide.
Founded in 1997, NCC has developed a strong technological foundation in electrophysiology equipment including EEG systems, intraoperative neuromonitoring platforms, polysomnography devices, electromyography systems, and a wide range of medical consumables. Through continuous research and development, NCC delivers solutions that meet the evolving needs of modern neurological diagnostics and clinical monitoring.
NCC is honored as a national “Little Giant” SRDI Enterprise, a prestigious designation recognizing companies that demonstrate excellence in specialized technologies, innovation capability, and industry leadership. This recognition reflects NCC’s commitment to developing core patented technologies and high-precision medical equipment for neurodiagnostic applications.
The company operates an integrated global structure designed to support innovation, manufacturing efficiency, and international market expansion.
Research, Development and Manufacturing
NCC’s primary research and production facilities are located in Shanghai, China, one of the world’s most dynamic technology and manufacturing hubs. Here, multidisciplinary teams of engineers, neuroscientists, and medical specialists collaborate to develop cutting-edge neurophysiology solutions.
The manufacturing facilities employ advanced precision production technologies and rigorous quality control procedures to ensure that every device meets international medical standards. From circuit design and component testing to final system calibration, every step of production is carefully controlled to guarantee performance reliability.
Quality and Compliance
To support global regulatory compliance, NCC maintains quality management operations in Singapore. This global hub ensures that NCC products meet international medical device standards and regulatory requirements across multiple markets.
Through strict quality management systems and continuous compliance monitoring, NCC guarantees that its neurodiagnostic solutions meet the highest standards of safety, accuracy, and reliability.
Global Market Presence
NCC’s neurophysiology systems are currently used in more than 50 countries worldwide and are deployed in over 5,000 hospitals across China. From large teaching hospitals to specialized neurology centers, NCC technologies support clinicians in diagnosing neurological disorders and improving patient outcomes.
The company’s international distribution network spans Southeast Asia, Australia, Europe, the Americas, and Africa. Through close partnerships with distributors and clinical institutions, NCC continues to expand its global presence while providing localized technical support.
Training and Professional Support
NCC operates 31 training and technical support centers throughout China and is actively developing an international training ecosystem. Through the NCC Innovation Academy, clinicians and biomedical engineers receive professional training in EEG, EMG, and intraoperative neuromonitoring technologies.
This education platform supports continuous professional development and encourages multidisciplinary collaboration among neurologists, neurosurgeons, anesthesiologists, and biomedical engineers.
Mission and Vision
NCC’s mission is to safeguard life and health by delivering innovative neurodiagnostic technologies that enable safer surgeries, more accurate neurological diagnosis, and improved patient care.
By combining technological innovation, global collaboration, and professional training programs, NCC continues to advance the field of neurophysiology and contribute to the development of modern neurological healthcare systems.
Copyright © NCC Medical Co., Ltd. - Privacy policy